Merck Tbk
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an… Read more
Merck Tbk (MERK) - Total Assets
Latest total assets as of September 2025: Rp987.93 Billion IDR
Based on the latest financial reports, Merck Tbk (MERK) holds total assets worth Rp987.93 Billion IDR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Merck Tbk - Total Assets Trend (2000–2024)
This chart illustrates how Merck Tbk’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Merck Tbk - Asset Composition Analysis
Current Asset Composition (December 2024)
Merck Tbk's total assets of Rp987.93 Billion consist of 74.2% current assets and 25.9% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 9.2% |
| Accounts Receivable | Rp180.19 Billion | 18.8% |
| Inventory | Rp391.92 Billion | 41.0% |
| Property, Plant & Equipment | Rp211.90 Billion | 22.1% |
| Intangible Assets | Rp1.89 Billion | 0.2% |
| Goodwill | Rp0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Merck Tbk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Merck Tbk's current assets represent 74.2% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 9.2% of total assets in 2024, down from 19.9% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 41.0% of total assets.
Merck Tbk Competitors by Total Assets
Key competitors of Merck Tbk based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Merck Tbk - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Merck Tbk generates 1.08x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Merck Tbk generates $ 16.04 in net profit.
Merck Tbk - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.76 | 4.53 | 2.55 |
| Quick Ratio | 3.79 | 1.70 | 1.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp647.46 Billion | Rp 522.16 Billion | Rp 412.06 Billion |
Merck Tbk - Advanced Valuation Insights
This section examines the relationship between Merck Tbk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.63 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -0.1% |
| Total Assets | Rp956.94 Billion |
| Market Capitalization | $11.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Merck Tbk's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Merck Tbk's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Merck Tbk (2000–2024)
The table below shows the annual total assets of Merck Tbk from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp956.94 Billion | -0.09% |
| 2023-12-31 | Rp957.81 Billion | -7.69% |
| 2022-12-31 | Rp1.04 Trillion | +1.11% |
| 2021-12-31 | Rp1.03 Trillion | +10.36% |
| 2020-12-31 | Rp929.90 Billion | +3.20% |
| 2019-12-31 | Rp901.06 Billion | -28.66% |
| 2018-12-31 | Rp1.26 Trillion | +49.13% |
| 2017-12-31 | Rp847.01 Billion | +13.85% |
| 2016-12-31 | Rp743.93 Billion | +15.94% |
| 2015-12-31 | Rp641.65 Billion | -10.46% |
| 2014-12-31 | Rp716.60 Billion | +2.82% |
| 2013-12-31 | Rp696.95 Billion | +22.39% |
| 2012-12-31 | Rp569.43 Billion | -2.56% |
| 2011-12-31 | Rp584.39 Billion | +34.41% |
| 2010-12-31 | Rp434.77 Billion | +0.18% |
| 2009-12-31 | Rp433.97 Billion | +15.71% |
| 2008-12-31 | Rp375.06 Billion | +13.29% |
| 2007-12-31 | Rp331.06 Billion | +17.11% |
| 2006-12-31 | Rp282.70 Billion | +29.66% |
| 2005-12-31 | Rp218.03 Billion | +8.76% |
| 2004-12-31 | Rp200.47 Billion | +0.07% |
| 2003-12-31 | Rp200.33 Billion | +16.24% |
| 2002-12-31 | Rp172.34 Billion | +5.91% |
| 2001-12-31 | Rp162.72 Billion | +25.47% |
| 2000-12-31 | Rp129.68 Billion | -- |